34 related articles for article (PubMed ID: 38507078)
1. FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma.
Liao Z; Fan H; Weng J; Zhou J; Zheng Y
Anal Cell Pathol (Amst); 2024; 2024():8810804. PubMed ID: 38826849
[TBL] [Abstract][Full Text] [Related]
2. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
3. FRZB: a potential prognostic marker for head and neck squamous cell carcinoma.
Li Y; Gu F; Huang X; Huang W; Xiang J; Yue J; Wang Y; Chen R
Braz J Med Biol Res; 2024; 57():e13368. PubMed ID: 38775547
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
[TBL] [Abstract][Full Text] [Related]
5. Alteration of SERPINH1 is associated with elevated expression in head and neck squamous cell carcinomas and its clinicopathological significance.
Murugesan D; Kannan B; As SG; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101811. PubMed ID: 38432483
[TBL] [Abstract][Full Text] [Related]
6. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma.
Li R; An P; Lin X; Liu X; Zhao L; He Y
Int J Oral Maxillofac Surg; 2024 Jun; 53(6):461-469. PubMed ID: 37923576
[TBL] [Abstract][Full Text] [Related]
8. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
[TBL] [Abstract][Full Text] [Related]
9. Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer.
Nguyen PT; Shimojukkoku Y; Kajiya Y; Oku Y; Tomishima A; Shima K; Sasahira T
PLoS One; 2024; 19(5):e0300446. PubMed ID: 38820302
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the Functional Roles and Immunological Features of Chemokines in COAD.
Xu H; Song Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791448
[TBL] [Abstract][Full Text] [Related]
11. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC.
Wang L; He Y; Bai Y; Zhang S; Pang B; Chen A; Wu X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):198. PubMed ID: 38625586
[TBL] [Abstract][Full Text] [Related]
13. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
14. EZH2 Expression in Head-and-Neck Squamous Cell Cancer in Young Patients.
Révész M; Oberna F; Slezák A; Tóth E; Ferenczi Ö; Kenessey I; Takácsi-Nagy Z
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791289
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein methyltransferases 5 associated with ferroptosis and immune cell infiltration of head and neck squamous cell carcinoma.
Zhang X; Liu Q; Wang L; Peng Q
Aging (Albany NY); 2024 Apr; 16(8):7426-7436. PubMed ID: 38663941
[TBL] [Abstract][Full Text] [Related]
16. Mouse Models for Head and Neck Squamous Cell Carcinoma.
Zhou J; Liu C; Amornphimoltham P; Cheong SC; Gutkind JS; Chen Q; Wang Z
J Dent Res; 2024 Jun; 103(6):585-595. PubMed ID: 38722077
[TBL] [Abstract][Full Text] [Related]
17. TRIM Expression in HNSCC: Exploring the Link Between Ubiquitination, Immune Infiltration, and Signaling Pathways Through Bioinformatics.
Wang K; Zhu W; Huang W; Huang K; Luo H; Long L; Yi B
Int J Gen Med; 2024; 17():2389-2405. PubMed ID: 38808201
[TBL] [Abstract][Full Text] [Related]
18. SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration.
Jiang W; Xu S; Li P
Curr Gene Ther; 2024 May; ():. PubMed ID: 38778609
[TBL] [Abstract][Full Text] [Related]
19. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
